US Patent 8835501 Pharmaceutical formulations of HDAC inhibitors

Patent 8835501 was granted and assigned to Topotarget UK Limited on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Topotarget UK Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88355010

Patent Inventor Names

Nicholas J. Hughes0

Richard J. Bastin0

Date of Patent

September 16, 2014

Patent Application Number

119131910

Date Filed

May 11, 2006

Patent Citations Received

‌

US Patent 11919839 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Patent Primary Examiner

‌

Anna Pagonakis

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8835501 Pharmaceutical formulations of HDAC inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API